Clinical trials provide Canadian oncology patients with earlier access to new, innovative cancer treatments. But changes pending to the PMPRB will make the Canadian pharmaceutical market less attractive for investment.
Note de recherche: Essais cliniques en oncologie: La position du Canada dans le contexte international
